Effects of topoisomerase II inhibitors on gastric cancer cells characterized by different genetic lesions. [electronic resource]
Producer: 20011207Description: 2803-8 p. digitalISSN:- 0250-7005
- Antibiotics, Antineoplastic -- pharmacology
- Antineoplastic Agents, Phytogenic -- pharmacology
- Cell Cycle -- drug effects
- Cell Death -- drug effects
- Cyclin-Dependent Kinase Inhibitor p21
- Cyclins -- biosynthesis
- DNA Topoisomerases, Type II -- biosynthesis
- Doxorubicin -- pharmacology
- Enzyme Inhibitors -- pharmacology
- Etoposide -- pharmacology
- Flow Cytometry
- Genes, p53 -- genetics
- Humans
- Polymerase Chain Reaction
- Stomach Neoplasms -- drug therapy
- Topoisomerase II Inhibitors
- Transcriptional Activation
- Tumor Cells, Cultured
- Tumor Suppressor Protein p53 -- biosynthesis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.